ライフサイエンスコーパス: reproductive age

1 ed to an increasing number of obese women of reproductive age.

2 r Xa inhibitors in a case series of women of reproductive age.

3 percent were male, and 73% of women were of reproductive age.

4 nce was 1.0 case (0.3-2.4) per 1000 women of reproductive age.

5 se substitutions tend to go up with paternal reproductive age.

6 on and overweight and obesity among women of reproductive age.

7 credible interval 1.3-5.5) per 1000 women of reproductive age.

8 wide leading vaginal disorder among women of reproductive age.

9 <5 y old, school-aged children, and women of reproductive age.

10 ttings, especially for HIV-positive women in reproductive age.

11 follicles and defective oocytes at advanced reproductive age.

12 hological problems, particularly in women of reproductive age.

13 osomiasis affects nearly 40 million women of reproductive age.

14 oids) are the most common tumors in women of reproductive age.

15 common endocrine disorder affecting women of reproductive age.

16 ontribute to obesity development in women of reproductive age.

17 e articles relevant to both men and women of reproductive age.

18 f T4 bound to TTR (T4-TTR) in Inuit women of reproductive age.

19 utplanted juveniles for 4 months, halfway to reproductive age.

20 ) in connection with cancer treatment during reproductive age.

21 ulation compared with that of other women of reproductive age.

22 workers compared with that for all women of reproductive age.

23 Hypertension occurs in about 8% of women of reproductive age.

24 age at menarche with changes in hormones by reproductive age.

25 increasing burden of obesity among women of reproductive age.

26 sion of a large number of cells at a defined reproductive age.

27 increased educational attainment in women of reproductive age.

28 nce of the metabolic syndrome among women of reproductive age.

29 ary 2008 on bariatric surgery among women of reproductive age.

30 lower genital tract syndrome among women of reproductive age.

31 e past 10 years, particularly among women of reproductive age.

32 factor in cognitive performance in women of reproductive age.

33 counseling of affected individuals who reach reproductive age.

34 istent chemicals widely detected in women of reproductive age.

35 omata are the most common tumors in women of reproductive age.

36 e most common endocrine disorder in women of reproductive age.

37 an incidence rate as high as 70% in women of reproductive age.

38 lity, calculated per population for women of reproductive age.

39 oup analysis assessed predictors in women of reproductive age.

40 ccurs at all ages but especially in women of reproductive age.

41 is infection in nonpregnant women and men at reproductive age.

42 and screening coverage than US-born women of reproductive age.

43 oup analysis assessed predictors in women of reproductive age.

44 is (BV) is a common condition among women of reproductive age.

45 reduced risk of new-onset asthma in women of reproductive age.

46 se may be the preferred surgery for women of reproductive age.

47 D are higher in men than in women during the reproductive age.

48 order affecting 6%-10% of all women in their reproductive age.

49 gic asthma observed between men and women of reproductive age.

50 d reproductive potential among women of late reproductive age.

51 s a significant number of women during their reproductive ages.

52 ted women, hepatic fibrosis accelerates with reproductive aging.

53 ory health might deteriorate in women during reproductive aging.

54 d rate of reproduction and an early onset of reproductive aging.

55 imultaneous amelioration of both somatic and reproductive aging.

56 e changes account for the overall pattern of reproductive aging.

57 respiratory health often deteriorates during reproductive aging.

58 We investigated all deaths in women of reproductive age (12-49 years) since January, 2008, usin

59 For women of reproductive age (15-44 years) in developing countries,

60 Among women of reproductive age (15-44 years), pregnant women had a mar

61 hting block groups by the number of women of reproductive age (15-44 years).

62 All women of reproductive age (15-45 years) who gave informed consent

63 from under- to overnutrition) among women of reproductive age (15-49 y) is becoming increasingly comm

64 ment, and care of HIV infection for women of reproductive age (15-49 years of age).

65 ates that enable monitoring for all women of reproductive age (15-49 years) (WRA), including unmarrie

66 aceptive prevalence rates among all women of reproductive age (15-49 years) varied from as low as 0.7

67 households in each cluster, and one woman of reproductive age (15-49 years) was randomly selected in

68 All married women of reproductive age (15-49 years) were eligible to particip

69 se outcomes is well established for women of reproductive age (15-49 years) who are married or in a u

70 did a retrospective cohort study of women of reproductive age (15-49 years) who died between March 21

71 Study participants were women of reproductive age (15-49 years) who gave birth between Se

72 aharan Africa and included data for women of reproductive age (15-49 years).

73 during home visits to all resident women of reproductive age (15-49 years).

74 sfied demand for family planning by women of reproductive age (19% vs 63%).

75 We analyze glymphatic influx in 244 young reproductive age (2-4 months) C57BL/6 mice.

76 he global burden of tuberculosis in women of reproductive age; (2) how pregnancy and the postpartum p

77 all men and in addition to (1) women beyond reproductive age; (2) women beyond reproductive age or u

78 concentration >300 mug/L) in HEIRS women of reproductive age (25-44 y).The HEIRS Study was a cross-s

79 men (3% vs 10%, P < 0.001) and for women of reproductive age (6.9% vs 24.7%, P < 0.001).

80 ternal mortality rate (1.7 per 1000 women of reproductive age, 95% CI 1.3-2.1 in Ragh vs 0.2, 0.1-0.3

81 We analyzed data for women of reproductive age according to whether or not they were p

82 ransgender women compared with all adults of reproductive age across the 15 countries was 48.8 (95% C

83 Our results clearly show that parental reproductive age affects somatic mutation rates in the p

84 ivities related to HIV infection in women of reproductive age affects the amount of ODA received by p

85 d reducing conditions prevail throughout the reproductive age, after which age-accompanied protein ox

86 eline ART and immune function by GBD region, reproductive aging among cisgender women, and data on th

87 elevated iron stores are present in women of reproductive age and are influenced by ethnicity and HFE

88 re the most common pelvic tumors in women of reproductive age and are the primary indication for hyst

89 term follow-up of children born after ART to reproductive age and beyond is necessary.

90 ogy of Fallot (TOF) now routinely survive to reproductive age and beyond.

91 pausal age was elevated by 34% compared with reproductive age and by 16% compared with menopause (mul

92 ssess: (i) changes in hormones (outcomes) by reproductive age and chronological age (these age variab

93 lthy maternal nutrition and weight status at reproductive age and during pregnancy, as well as carefu

94 o do not have signs or symptoms of abuse) of reproductive age and elderly and vulnerable adults.

95 ng between US-born and foreign-born women of reproductive age and examines predictors.

96 e and carrier female mice are viable through reproductive age and fertile.

97 is affects approximately 40 million women of reproductive age and has been linked to elevated levels

98 intake in nonpregnant, nonlactating women of reproductive age and in nonbreastfed children 1-3 y old

99 eficiency is most commonly found in women of reproductive age and infants worldwide, but the influenc

100 is a relatively common condition in women of reproductive age and is associated with considerable mor

101 Endometriosis affects 10-20% of women of reproductive age and is associated with pelvic pain and

102 Women of reproductive age and particularly pregnant women are the

103 nterventions for schistosomiasis in women of reproductive age and preschool-age children, and the nee

104 r >20 y to improve folate status in women of reproductive age and reduce the risk of folic acid-respo

105 Differences were not exclusively related to reproductive age and thus cannot be attributed to sex ho

106 Women of reproductive age and young children are largely neglecte

107 ntial effects of schistosomiasis in women of reproductive age and young children.

108 ive aging, including the correlation between reproductive aging and declining oocyte quality and mech

109 pecific signaling events, the progression of reproductive aging and somatic aging is systemically coo

110 ical condition reported by 5-10% of women of reproductive age, and in turn, because up to half of wom

111 a common gynaecological disease of women in reproductive age, and is thought to arise from retrograd

112 rial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatme

113 min D status for infants, children, women of reproductive age, and specific ethnic groups.

114 relating WHR to BMI for white UK females of reproductive age, and used this function to statisticall

115 es are increasingly targeted toward women of reproductive age, and vaccines to prevent influenza and

116 Why do humans survive so long past reproductive age, and why does juvenile mortality declin

117 Sma/Mab pathway in the hypodermis to control reproductive aging, and that it does so by regulating a

118 Women of reproductive age are among those most vulnerable to iron

119 Women of reproductive age are considered the population at greate

120 In the United States, one-third of women of reproductive age are obese.

121 ergy substrate and likelihood of survival to reproductive age are particularly salient drivers of fet

122 es of female gonadal function in patients of reproductive age are recognized, however, pathological a

123 Data on obesity status among men of reproductive age are scarce.

124 both worms and humans, mechanisms regulating reproductive aging are not yet understood.

125 the most common type of tumor among women of reproductive age, are associated with heavy menstrual bl

126 g., using exposures estimated among women of reproductive age as a proxy for maternal exposures, or e

127 for association with seven traits related to reproductive (age at natural menopause, number of childr

128 sed rates of fibrosis compared with women of reproductive age because they have lost the protective e

129 mponents of the ejaculate contribute to male reproductive aging but reveal a mismatch in their aging

130 ase menstrual bleeding intensity in women of reproductive age, but the extent of this effect is unkno

131 beverages are widely consumed among women of reproductive age, but their association with reproductiv

132 Insulin/IGF-1 signaling regulate C. elegans reproductive aging by modulating multiple aspects of the

133 pread development of carcinogenesis at early reproductive ages, compromised spermatogenesis, and feta

134 ographic parameters associated with advanced reproductive age (controlling for chronologic age) inclu

135 Unexplained infertility affects 2%-3% of reproductive-aged couples.

136 the modelled rates in subgroups of women of reproductive age defined by their marital status and con

137 For women of reproductive age, detailed information on new pregnancy

138 In a population of 90 816, 357 women of reproductive age died; 154 deaths were related to compli

139 In this model, ovarian reproductive aging displays similarities with chronic in

140 mplications for human infertility, premature reproductive aging due to oxidative stress, and gonadopr

141 Limited recruitment to reproductive age, even under weak annual selection advan

142 rtility in hundreds of thousands of women of reproductive age every year.

143 to millions of patients, including women of reproductive age, exposure to DOACs in early pregnancy i

144 sociated with subclinical autoimmunity among reproductive-age females.

145 had higher sputum %neutrophils than nonobese reproductive-aged females (45.4 +/- 24.3% vs 27.5 +/- 17

146 Obese reproductive-aged females had higher sputum %neutrophils

147 Reproductive-aged females using the OCP had significantl

148 associated with lower sputum %neutrophils in reproductive-aged females warrants further investigation

149 Thirteen (36.1%) reproductive-aged females were using the OCP.

150 al measures of glucocorticoid metabolites in reproductive-aged females, which peak during heavy workl

151 these were prevented by a low proportion of reproductive-aged females.

152 15 fallopian tubes (FT) from 14 women in reproductive age from procedures for benign disease or s

153 Four datasets of women of reproductive age from the Egyptian Demographic and Healt

154 Foreign-born women of reproductive age had lower hepatitis B vaccination and s

155 Approximately 20-35% of European women of reproductive age had sufficient iron stores (SF concentr

156 n humans, it is well known that the parental reproductive age has a strong influence on mutations tra

157 contrast, it is unknown whether the parental reproductive age has an effect on somatic mutation rates

158 Each year, about 2% of all women of reproductive age have an abortion.

159 Most women of reproductive age have some physical discomfort or dyspho

160 n for height and life history traits such as reproductive age; however, the latter appear to result f

161 ers were all ever-married women and girls of reproductive age (ie, aged 15-49 years) who became pregn

162 e fell; and the education levels of women of reproductive age improved substantially.

163 cy trends from 1992 through 2009 in women of reproductive age in British Columbia, Canada.

164 the third leading cause of death in women of reproductive age in Kabul, and the leading cause in Ragh

165 , and 25-DCP were higher than among women of reproductive age in the US general population, while con

166 g (FP) use have been reported among women of reproductive age in union (WRAU) in Senegal.

167 rformed a forward genetic screen for delayed reproductive aging in C. elegans.

168 During reproductive aging in female rats, there is a loss of Gn

169 By conducting screens focused on reproductive aging in mated hermaphrodites, we identifie

170 Our data suggest reproductive aging in rats is characterized by structura

171 nological age and time around the menopause (reproductive age) in mid-life women and explored their a

172 C. elegans and humans share many aspects of reproductive aging, including the correlation between re

173 15, 2015, from expanded carrier screening in reproductive-aged individuals without known indication f

174 ong WWH in the REPRIEVE trial, more advanced reproductive age is associated with metabolic dysregulat

175 ention of overweight and obesity in women of reproductive age is important to improve perinatal healt

176 Obesity in women of reproductive age is increasing in prevelance worldwide.

177 of exposure to methylmercury in US women of reproductive age is not known.

178 Prevention of obesity in women of reproductive age is widely recognised to be important bo

179 Females were further categorized as reproductive-aged (<50 years old; n = 36) or older (>50

180 We previously reported that neutrophils from reproductive-age males are more immature and less activa

181 Reproductive aging may contribute to cardiometabolic com

182 These included 19 young women of reproductive age (mean [SD], 28.26 [5.05] years), 27 wom

183 In European women of reproductive age, median or geometric mean serum ferriti

184 ce and trend of overweight and obesity among reproductive-age men in rural China.

185 diometabolic and demographic parameters with reproductive aging milestones (AMH <20 pg/mL or >12 mont

186 Among women of reproductive age (n = 24216), the reported hepatitis B v

187 eeding, is a common complication in women of reproductive age on direct oral factor Xa inhibitor ther

188 If only men and women beyond reproductive age or on contraception are started on or s

189 en beyond reproductive age; (2) women beyond reproductive age or using contraception; and (3) all wom

190 mesh herniorrhaphy, men, especially of young reproductive age or with a solitary testicle, need to be

191 ver, little is known about genes that affect reproductive aging or aging of specific somatic tissues.

192 The survival rate of reproductive-age patients with cancer is increasing, ref

193 anti-mullerian hormone [AMH)] to interrogate reproductive aging patterns and associated factors among

194 eading to the bluish-white glaucous trait in reproductive-age plants.

195 f maternal deaths among deaths of females of reproductive age (PMDF) for each 5-year age group from 1

196 the most prevalent pelvic tumors in women of reproductive age, pose a major public health problem giv

197 rdial infarction is a rare event in women of reproductive age, pregnancy increases the risk 3- to 4-f

198 c lupus erythematosus (SLE) affects women of reproductive age, pregnancy is a major concern.

199 se burden caused by malnutrition in women of reproductive age, pregnancy, and children in the first 2

200 omen are limited, and thus, data on women of reproductive age provide useful background information i

201 ndergoes many more cell divisions across the reproductive age range, copy errors taking place in the

202 p meant that a sizeable fraction of women of reproductive age received PsA-TT.

203 or its precursor (betacarotene) in women of reproductive age reduced pregnancy-related mortality by

204 success), which was most pronounced at early reproductive ages (RR 2.92 [95% CI 1.18-7.20], p=0.020,

205 ngitudinal analyses of fibrosis rates across reproductive age should be conducted in non-HCV-related

206 d not smoke while pregnant, and all women of reproductive age should be warned that smoking increases

207 d not smoke while pregnant, and all women of reproductive age should be warned that smoking increases

208 diopathic constipation is higher in women of reproductive age than postmenopausal women or men, sugge

209 n in-hospital mortality in women with CHD of reproductive age that did not correlate with increased m

210 (PCOS) is a hormonal disorder of females of reproductive age that impacts their oral and systemic he

211 In the majority of women of reproductive age, the microbiota of the lower FRT (vagin

212 obin concentration <12 g/dL) Indian women of reproductive age.The Let's be Well Red study was a 90-d,

213 increasing prevalence of obesity in women of reproductive age there is a need to understand the ramif

214 f prospectively collected data from women of reproductive age treated with direct oral factor Xa inhi

215 CV), we assessed fibrosis progression across reproductive age, using validated serum fibrosis markers

216 mated prevalence of hypertension in women of reproductive age was 7.7% (95% confidence interval (CI):

217 ent and maintained at a constant level until reproductive age was achieved.

218 n in determining AMH levels in women of late reproductive age, we carried out a genome-wide meta-anal

219 To understand reproductive aging, we analyzed the assembly line of ooc

220 Causes of death in women of reproductive age were ascertained by verbal autopsy.

221 uestions applicable to both men and women of reproductive age were considered; studies were excluded

222 Deaths among women of reproductive age were identified through a survey of all

223 From June 2014 to March 2017, 1214 women of reproductive age were recruited and followed monthly unt

224 ided by prevention of obesity among women of reproductive age, which should be viewed as a global pub

225 level, Asia has seen the mCPR among women of reproductive age who are married or in a union grow from

226 dern methods of contraception among women of reproductive age who are married or in a union in the fo

227 In 2017, the mCPR among women of reproductive age who are married or in a union in the FP

228 Between 2012 and 2017 the number of women of reproductive age who are married or in a union who use m

229 of additional users up to 2017 for women of reproductive age who are married or in a union would sug

230 nception counseling is mandatory in women of reproductive age who are scheduled for a kidney transpla

231 Women of reproductive age who follow a low-carbohydrate dietary p

232 Women of reproductive age who have received a solid-organ transpl

233 We identified 178 women of reproductive age who received direct oral factor Xa inhi

234 Women of reproductive age who smoke should be strongly encouraged

235 stpartum women, and 137 nonpregnant women of reproductive age who were hospitalized with 2009 H1N1 in

236 e a major source of gynecologic morbidity in reproductive age women and are characterized by the exce

237 esign to generate a representative sample of reproductive age women from the Central Zone of Tigray,

238 Using data from a panel survey of reproductive age women in Egypt, we estimate the effects

239 nfertility and affects approximately 4-7% of reproductive age women in the U.S.

240 PCOS), the most common endocrine disorder of reproductive age women.

241 stant, inflammatory gynecological disease of reproductive age women.

242 lycystic ovary syndrome (PCOS) affects 5% of reproductive aged women and is the leading cause of anov

243 e comparable to published data on DPV use in reproductive-age women (median plasma concentration: 264

244 myomatosis (LAM) is a metastatic neoplasm of reproductive-age women associated with mutations in tube

245 Reproductive-age women need effective interventions to p

246 Thirty-two reproductive-age women self-collected midvaginal swabs t

247 ough August 11, 2009, for all H1N1-infected, reproductive-age women who were hospitalized or died--no

248 iladelphia County, Pennsylvania, of 203 late-reproductive-age women who were premenopausal at baselin

249 e symptomatic and relapse-prone phenotype in reproductive-age women with bipolar disorder.

250 discusses concerns specific to children and reproductive-age women with narcolepsy, and reviews the

251 plex genetic disorder affecting up to 15% of reproductive-age women worldwide, depending on the diagn

252 ased follicle-stimulating hormone values for reproductive-age women, and/or treatment with hormone re

253 eiomyomata (UL), the most common neoplasm in reproductive-age women, are classified into distinct gen

254 As with cystitis in reproductive-age women, sexual behaviors and patient and

255 Thus, ovaries of reproductive-age women, similar to adult mice, possess r

256 In older reproductive-age women, the frequent existence of anovul

257 treat a spectrum of psychiatric illnesses in reproductive-age women.

258 novulation, and infertility, affects 5-7% of reproductive-age women.

259 a, and recurrent pregnancy loss in 15-30% of reproductive-age women.

260 in other countries may affect the health of reproductive-age women.

261 use were associated with new-onset asthma in reproductive-age women.

262 leiomyoma is the most common benign tumor in reproductive-age women.

263 infertility, affecting approximately 10% of reproductive-age women.

264 trium that significantly affect up to 30% of reproductive-age women.

265 Of 729 reproductive-aged women admitted to study ETUs, 44 (6%)

266 infection reported to the NNDSS; 2.1 million reproductive-aged women and 56 684 children who had HCV

267 s and Quest laboratory data regarding unique reproductive-aged women and children who were tested for

268 romatase, highly expressed in the ovaries of reproductive-aged women and in the brains of men and wom

269 We prospectively enrolled a cohort of reproductive-aged women and matched men on suppressive A

270 est a recent increase in HCV infection among reproductive-aged women and may inform deliberations reg

271 drugs, but the extent of this epidemic among reproductive-aged women and their children is unknown.

272 We followed 300 000 reproductive-aged women for 10 years for ectopic pregnan

273 The vaginal microbiota of reproductive-aged women is largely made up of at least f

274 health and of the effect of these intakes in reproductive-aged women is warranted.

275 We analyzed a retrospective cohort of reproductive-aged women presenting to 5 West African ETU

276 The factors that predispose one-tenth of reproductive-aged women to endometriosis are poorly unde

277 Folic acid is recommended to reproductive-aged women to prevent birth defects, though

278 suggest that, in Europe, the iron status of reproductive-aged women varies by region and worsens in

279 The number of reproductive-aged women with acute and past or present H

280 mate numbers and describe characteristics of reproductive-aged women with HCV infection and of their

281 ew-onset depression in 2 populations of late-reproductive-aged women with no Diagnostic and Statistic

282 k-skinned individuals, infants, adolescents, reproductive-aged women, and pregnant and lactating wome

283 In reproductive-aged women, shedding frequency and magnitud

284 eproductive tract, occurring in up to 77% of reproductive-aged women, yet molecular pathogenesis rema

285 mation operatorandrogen-disruptor among 2842 reproductive-aged women.

286 etriosis affects approximately 10% of young, reproductive-aged women.

287 CRP measurement to menstrual cycle phase in reproductive-aged women.

288 perimenopausal age group, meeting Stages of Reproductive Aging Workshop criteria for perimenopause,

289 asingly high rates of obesity among women of reproductive age worldwide and the importance of breastf

290 dren (PSC) (age range: 6-59 mo) and women of reproductive age (WRA) (age range: 15-49 y) and investig

291 dren (PSC) (age range: 6-59 mo) and women of reproductive age (WRA) (age range: 15-49 y) and investig

292 dren (PSC) (age range: 6-59 mo) and women of reproductive age (WRA) (age range: 15-49 y) and to inves

293 Anemia in women of reproductive age (WRA) (age range: 15-49 y) remains a pu

294 dren (PSC) (age range: 6-59 mo) and women of reproductive age (WRA) (age range: 15-49 y).Cross-sectio

295 dren (PSC) (age range: 6-59 mo) and women of reproductive age (WRA) (age range: 15-49 y).Cross-sectio

296 and from 10 surveys for nonpregnant women of reproductive age (WRA) (n = 25,731) from the Biomarkers

297 mia in preschool children (PSC) and women of reproductive age (WRA).The BRINDA database inclusion cri

298 For example, 62.5% and 29.6% of women of reproductive age (WRA, n = 802) had plasma Se concentrat

299 dren (PSC; 6-59 mo) and nonpregnant women of reproductive age (WRA; 15-49 y), and to compare differen

300 um and RBC folate among nonpregnant women of reproductive age (WRA; 15-49 yr) and preschool children